Skip to content
Recall Observatory FDA recall evidence

Drug product

Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.

D-0551-2023

March 16, 2023

Class II

Product summary

Firm
Northwind Pharmaceuticals LLC
Event
Event 91944
Status
Ongoing
Classification
Class II
Quantity
a) 230 bottles; b) 22 bottles
Official record key
drug-enforcement:D-0551-2023

Official wording

Reason: CGMP Deviations

Code information: a) Lot #: F106252201, Exp. Date 09/30/2024; F106252301, F106252303, Exp. Date 5/31/2025; F106252304, Exp. Date 07/31/2025 b) Lot #: F106252302, Exp. Date 07/31/2025

Distribution pattern: Nationwide with the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations